Biotech RadarJobs updated

COMPANY

Epirium Bio

epirium.com ↗

Clinical Phase 1

Epirium Bio is a biopharmaceutical company that has identified and established an IP-protected platform of orally bioavailable small molecules that leverages the potential of PGE-2 signaling to restore tissue homeostasis, resolving aberrant inflammation, stimulating regeneration, and reducing fibrosis. From company website Source · Oct 13, 2026

Keywords: biopharmaceutical small molecules Becker Muscular Dystrophy

Profile checked Oct 10, 2026

2Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: Single and Multiple Ascending Dosing Administration of MF-300 in Healthy Participants source ↗
  2. Trial start Phase 1: Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy source ↗

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT07613684Single and Multiple Ascending Dosing Administration of MF-300 in Healthy ParticipantsPhase 1CompletedDec 20, 2024Oct 9, 2025 (actual)
NCT04386304Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular DystrophyPhase 1CompletedJul 13, 2020Mar 1, 2022 (actual)
Feedback